T

Theratechnologies
D

THTX

1.23000
USD
0.02
(1.65%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
-31
Market Cap
56,555,423
News

Title: Theratechnologies

Sector: Healthcare
Industry: Biotechnology
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.